We have a vision: a world where access to medicine is global by design. 

No clinical trial supplies held back by practical challenges. 

No over-extended supply chains or unethical grey market mark-ups. 

No patient left behind by unnecessary delays or unfamiliarity with unlicensed access. 

A world where everyone, in every corner of the globe, has access to innovative, life-saving medicines. 

And we’re here to make that vision a reality. 

As pathfinders, we’re experts at navigating complexity and accelerating access to medicines to those that need them, whether in clinical trials, early access programmes, or long-term commercialisation (licensed and unlicensed pathways). 

Dedicated, open and collaborative, we guide our pharmaceutical and biotechnology clients at every step helping them to reach their goals and overcome their practical, regulatory and geographical obstacles. 

Harnessing our global network and local insight, our world-class team works together to impact lives everywhere. 

Whatever the challenge, we find a way. 

Get in touch


Clinical Services

Clinical development is getting more complex and harder to manage. 

Innovators are overburdened. Missteps lead to expensive delays.  

Too many outsource partners lack the experience to really help. Or they are built for a different generation of therapies, when scale and automation was enough.  

We are pathfinders for innovative medicines - offering genuine expertise, designed for agility and delivering industry best cycle times. 

Standard Banner - South Asian Female Doctor(Right Align).png

Product access and commercialisation

Disease doesnt wait. And it doesnt care where you live. 

We believe that access to medicine should be global by design, whether pre-approval, commercially available or long-term unlicensed.  

Work with us to make sure your access plans truly meet patient demand. 

Standard Banner - Female Doctor with Glasses_2 (Right Align).png

Lifecycle services

We offer the regulatory affairs and patient safety services that are critical to supporting and maintaining quicker, broader access to medicines.


Regulatory Affairs